Investor Relations

Press Releases

December 4, 2025

Press Release: Sanofi completes acquisition of Vicebio

November 25, 2025

Press Release: Sanofi and Regeneron’s Dupixent approved as the first targeted medicine in the EU in over a decade for chronic spontaneous urticaria

Read the Press Release

November 14, 2025

Press Release: Sanofi’s Teizeild recommended for EU approval by the CHMP for patients with stage 2 type 1 diabetes

Read the Press Release

See more press releases

Upcoming Events

12Dec

2025

Leerink Partners POLARxPRESS

13:30 - 14:30 EDT (Boston)

Conferences

16Dec

2025

Year-end late-stage pipeline review

Sanofi is pleased to invite investors and analysts to participate in a year-end late-stage pipeline review by R&D management on Tuesday, December 16, 2025.

17:15 CET (11:15 EST)

Presentations

Discover more

12Jan

2026

44rd Annual J.P. Morgan Healthcare

09:45 - 10:25 PST (San Francisco)

Conferences

Discover more

All our events

Karine Roblot, wearing a light green protective suit, operating steel equipment with lots of valves, gauges and tubing

Karine Roblot, Vaccine Formulation Technician, Val de Reuil, France

2024 20-F

Presenting our 2024 FORM 20-F.

30th Consecutive Year of Dividend Increase

Learn more

Dr. Lingaraju checks the health of Manikantan as his sister Geetha watches closely inside the Billigiri Ranganathaswamy Temple Tiger Reserve in Chamrajanagara district, Karnataka state, India

Environment, Social, Governance

As a global pharmaceutical company, we stretch everyday to deliver safe and sustainable innovation and play our part in addressing some of the world’s most pressing challenges.